InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Robbins Andrew R. Officer active across 2 companies, notably Harpoon Therapeutics, Inc.. Aggregated, 5 filings have been logged. Activity tracked since 27 November 2023. The latest transaction was filed on 19 May 2026 (Don). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Robbins Andrew R has filed 5 disclosures in total. The most recent filings we hold cover the period from 2023-11-28 to 2026-05-21, with buy and sell amounts of EUR 0 each in this recent sample. He is associated with Cogent Biosciences, Inc. as President and CEO, and with Harpoon Therapeutics, Inc. as Director.